Huber Martin H. Jr. Insider Trades

Insider Trading History

Track insider trading activity for Huber Martin H. Jr.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Actuate Therapeutics
Actuate Therapeutics ACTU
Director
Holding Value $29.3k 15,000 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.3k 15,000 shares
$2.42
$1.95
Actuate Therapeutics
Actuate Therapeutics ACTU
Director
Holding Value $0 0 shares
Last Trade
May 01, 2026 Sale
$90k 30,000 shares
$3.00
$1.95
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Director
Holding Value $2.06M 103,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$492k 24,000 shares
$20.48
$19.98
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $0 0 shares
Last Trade
Jan 06, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$278k 9,573 shares
$29.08
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $0 0 shares
Last Trade
Jan 06, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.21M 75,957 shares
$29.08
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $278k 9,572 shares
Last Trade
Sep 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.7k 2,012 shares
$7.31
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $388k 13,340 shares
Last Trade
Sep 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.8k 6,670 shares
$7.47
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $337k 11,584 shares
Last Trade
Sep 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.8k 6,670 shares
$7.47
$29.08
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Director
Holding Value $1.58M 79,000 shares
Last Trade
May 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$45k 5,000 shares
$8.99
$19.98
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Director
Holding Value $1.48M 74,000 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$366k 25,000 shares
$14.65
$19.98
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $3.57M 122,875 shares
Last Trade
Jan 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$69.3k 4,514 shares
$15.35
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $965k 33,188 shares
Last Trade
Jan 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$177k 11,062 shares
$16.02
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $23.7M 816,300 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.1M 816,300 shares
$16.02
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $3.7M 127,389 shares
Last Trade
Jan 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$177k 11,062 shares
$16.02
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $3.38M 116,327 shares
Last Trade
Sep 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.23M 50,423 shares
$44.25
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $4.85M 166,750 shares
Last Trade
Sep 11, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.38M 166,750 shares
$44.25
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $14.5M 500,250 shares
Last Trade
Sep 11, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.38M 166,750 shares
$44.25
$29.08
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Director
Holding Value $979k 49,000 shares
Last Trade
Feb 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$379k 17,000 shares
$22.28
$19.98
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $5.79M 199,125 shares
Last Trade
Jan 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15M 199,125 shares
$75.50
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
President, CEO
Holding Value $265k 9,102 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$287k 9,102 shares
$31.50
$29.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up